As shown in Fig 5C–5F, i.p. delivery of anti-CCL2, anti-VEGFA and anti-CCL2/VEGFA combination dramatically reduced lung tumor growth, angiogenesis, TAMs accumulation, and tumor metastasis in mice. Here, CCL2 is linked to neoplasm.